Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Masonic Cancer Center, University of Minnesota
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Ossium Health, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
Incyte Corporation
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
Medical College of Wisconsin
Thomas Jefferson University
Fred Hutchinson Cancer Center
Advice Pharma Group srl
Stanford University
Tampere University Hospital
Medical College of Wisconsin
M.D. Anderson Cancer Center
Prelude Therapeutics
Gruppo Italiano Trapianto di Midollo Osseo
Center for International Blood and Marrow Transplant Research
Bellicum Pharmaceuticals
Weprom
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Neovii Biotech
National Heart, Lung, and Blood Institute (NHLBI)
New York Blood Center
M.D. Anderson Cancer Center
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)